A voiding trial is a structured test to determine whether someone can urinate on their own after a urinary catheter is removed. The basic sequence is straightforward: the catheter comes out (sometimes after the bladder is filled to a set volume), the person is given time to void, and the amount of urine produced and left behind in the bladder is measured. But the details of how each step is performed, when the catheter is removed, what medications are given beforehand, and what counts as “passing” vary enough across clinical settings that the process deserves a closer look.
Why Voiding Trials Are Done
Catheters are placed for many reasons: after surgery, during acute urinary retention, or when someone is too ill to get to a bathroom. The longer a catheter stays in, the higher the risk of urinary tract infection and other complications. A voiding trial is the gatekeeping step that determines whether the catheter can safely come out. If you void adequately and don’t retain too much urine afterward, you pass the trial and the catheter stays out. If you can’t empty your bladder well enough, the catheter goes back in or you’re started on intermittent catheterization until your bladder function recovers.
The clinical context matters. After pelvic floor or urogynecologic surgery, voiding trials check whether surgical swelling or nerve effects are temporarily blocking normal urination. In men with benign prostatic enlargement who developed sudden urinary retention, a voiding trial (often called a “trial without catheter” or TWOC) tests whether the prostate obstruction has settled enough for urine to flow again. In spinal cord injury, where bladder management is an ongoing concern, the approach is less about a single pass-fail moment and more about transitioning from indwelling catheterization to intermittent catheterization or reflex voiding over time.1Spinal Cord. Monitoring of neurogenic bladder management from hospital admission until discharge in spinal cord injury units: the SIRCA study
The Two Main Approaches: Active Versus Passive
Voiding trials fall into two broad categories, and understanding the difference is the first real decision point in the process.
In an active voiding trial (sometimes called a backfill-assisted or retrograde-fill trial), the bladder is filled with a known volume of sterile saline through the catheter before it is removed. A common target is 300 mL, or until you feel the urge to void, whichever comes first. The catheter is then pulled, and you’re asked to urinate immediately. Because your bladder starts at a known fill level, the clinician can quickly compare how much you voided against what was put in.
In a passive voiding trial (also called an autofill or spontaneous-fill trial), the catheter is simply removed and you wait for your kidneys to produce enough urine to trigger the urge to go. This can take hours. You’re monitored during that waiting period, usually with periodic bladder scans, until you produce a void or a time limit is reached.
A randomized trial comparing the two found that active trials cut the time to first void by about three and a half hours. More striking, the active approach was linked to a roughly 63% reduction in urinary tract infections, with no difference in retention rates between the groups.2PubMed. Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial That infection reduction likely comes from less time spent with instruments in and around the urethra. Despite the faster voiding, actual discharge times didn’t differ much in that particular study, partly because discharge depends on many other factors besides bladder function.
A meta-analysis of urogynecologic surgery trials confirmed the pattern: backfill-assisted trials were about twice as likely to be passed in recovery compared to autofill trials.3PubMed Central. Methods of postoperative void trial management after urogynecologic surgery: a systematic review and meta-analysis A separate randomized trial after midurethral sling surgery found similar results, with women in the backfill group more than four times as likely to pass the trial in recovery.4PubMed. Infusion-fill method versus standard auto-fill trial of void protocol following a TVT-exact procedure: A randomised controlled trial The reason is intuitive: the bladder starts full and ready to go, rather than slowly accumulating urine while the patient waits.
Interestingly, after same-day minimally invasive hysterectomy, one study found that a passive approach worked well and could actually reduce hospital stay time and improve patient experience, suggesting that procedure type matters when choosing a method.5Journal of Minimally Invasive Gynecology. Active versus Passive Voiding Protocols after Same-day Minimally Invasive Hysterectomy
Step by Step: What Actually Happens
While protocols differ between hospitals and specialties, the core sequence of a backfill-assisted voiding trial looks like this:
- Bladder filling: Sterile normal saline is instilled through the existing catheter, typically up to 300 mL or until you report a strong urge to void. Some protocols use a smaller volume of around 200 mL depending on the clinical situation.
- Catheter removal: Once the target volume is reached, the catheter balloon is deflated and the catheter is withdrawn.
- Voiding attempt: You’re asked to urinate as soon as possible, usually within a set window. Privacy, a comfortable position, and running water nearby can all help. Sitting on a toilet rather than using a bedpan is preferred when feasible.
- Volume measurement: The voided volume is collected and measured, often using a “hat” collection device placed inside the toilet.
- Post-void residual check: The amount of urine left in the bladder after voiding is measured, either by a portable ultrasound bladder scanner or, less commonly, by briefly reinserting a catheter. This leftover volume is called the post-void residual, or PVR.
The entire active trial can be completed in under an hour in many cases. One urogynecologic surgery protocol described the process as filling to 300 mL, removing the catheter, prompting an immediate void, and then scanning or catheterizing for PVR, all during the recovery room stay.6PubMed Central. Improving Postoperative Efficiency: An Algorithm for Expedited Void Trials After Urogynecologic Surgery
For a passive trial, the process is the same except there’s no filling step. The catheter comes out and a waiting period begins, typically with a time limit of four to six hours. If you haven’t voided by then, the trial is usually considered failed. One protocol for postoperative patients required a spontaneous void of at least 150 mL within six hours.7American Journal of Obstetrics and Gynecology. Two pee or not two pee: a cost analysis of second postoperative void trials
What Counts as Passing
There is no single universal threshold for passing a voiding trial, which is one of the most confusing aspects for patients. Different institutions and specialties use different criteria, and this is a genuine area of ongoing debate.
Most protocols look at two things: how much you void and how much is left behind. A common standard requires voiding at least 150 mL at once and having a PVR below a set cutoff. But what that PVR cutoff should be varies. A cost-effectiveness analysis compared thresholds of 100, 150, and 200 mL for PVR after urogynecologic surgery. The 150 mL threshold turned out to be the most cost-effective, balancing the risk of missing true retention against unnecessary follow-up visits and emergency department trips. The 100 mL threshold was overly aggressive, flagging too many patients who would have been fine, while the 200 mL threshold missed some patients who genuinely needed further management.8PubMed. A Cost-Effectiveness Analysis of Post-Void Residual Bladder Scan Thresholds in the Postoperative Setting
Some clinicians also assess the force and quality of the urine stream, though a meta-analysis found that subjective assessment of stream force didn’t significantly change the accuracy of correctly identifying who passed or failed compared to objective volume measurements alone.3PubMed Central. Methods of postoperative void trial management after urogynecologic surgery: a systematic review and meta-analysis
How PVR Is Measured
The post-void residual measurement is central to interpreting the trial, and how it’s obtained matters. The gold standard is catheterization, but reinserting a catheter just to check residual volume introduces infection risk and discomfort. Portable ultrasound bladder scanners have largely replaced catheterization for this purpose in most settings.
These handheld devices bounce ultrasound waves off the bladder to estimate its volume. They correlate well with catheterized volumes. One study found a correlation of 0.79 between 3D scanner measurements and catheterized volumes, with scanners averaging only about 13 mL difference from the true volume.9Journal of Obstetrics and Gynaecology Canada. Accuracy of Bladder Scanning in the Assessment of Postvoid Residual Volume Other studies have found even tighter agreement, with newer devices achieving correlations above 0.93 and mean differences of less than 8 mL from the catheterized volume.10PubMed. Accuracy and precision of a new portable ultrasound scanner, the BME-150A, in residual urine volume measurement: a comparison with the BladderScan BVI 3000
There are pitfalls, though. Scanners can overestimate or underestimate depending on the volume range and the specific device. One study found that a particular scanner without real-time imaging overestimated volumes above 100 mL by about 16%, while a version with real-time imaging underestimated across the board by about 14%.11PubMed. Accuracy of post-void residual urine volume measurement using a portable ultrasound bladder scanner with real-time pre-scan imaging Pelvic masses like ovarian cysts or uterine fibroids can produce falsely elevated readings, because the scanner confuses the fluid-filled mass for a full bladder. In one study, several cases showed scan-to-catheterization discrepancies of up to 275 mL, all attributable to pelvic pathology discovered on subsequent imaging.10PubMed. Accuracy and precision of a new portable ultrasound scanner, the BME-150A, in residual urine volume measurement: a comparison with the BladderScan BVI 3000
When to Remove the Catheter
Timing of catheter removal has a surprisingly large effect on how the voiding trial goes. Two main questions come into play: how many days after surgery to try, and what time of day to pull the catheter.
Across a large body of evidence, shorter catheterization durations carry a trade-off. A Cochrane review of 68 trials involving over 9,000 patients found that earlier removal roughly doubled the chance of needing recatheterization, but cut the risk of symptomatic catheter-associated UTI by about half and reduced painful urination as well.12PubMed Central. Strategies for the removal of short‐term indwelling urethral catheters in adults A randomized trial after pelvic floor surgery found that an early voiding trial led to spontaneous voiding about 17 hours sooner in the per-protocol group, and patients were up and walking sooner as well.13PubMed Central. Early catheter removal after pelvic floor reconstructive surgery: a randomized trial
As for the time of day, there is good evidence favoring midnight removal over early morning. Patients whose catheters were removed at midnight voided larger volumes with their first attempt (about 270 mL versus 177 mL) and reached normal voiding patterns sooner, allowing earlier discharge.14British Journal of Nursing. Removal of urinary catheters: midnight vs 0600 hours A Cochrane review confirmed that midnight removal was associated with shorter hospital stays.15PubMed Central. Strategies for the removal of short-term indwelling urethral catheters in adults The thinking is that the bladder has several hours overnight to fill naturally, so the first void in the morning comes more easily and at a better volume.
Medications That Improve Success
For men with acute urinary retention caused by an enlarged prostate, starting an alpha-blocker medication before the voiding trial can significantly improve the odds of passing. Alpha-blockers relax the smooth muscle around the prostate and bladder neck, making it easier for urine to flow.
A Cochrane review pooling data from multiple trials found that about 60% of men on an alpha-blocker voided successfully after catheter removal, compared to about 38% on placebo. Recurrent retention episodes were also less common in the alpha-blocker group.16Cochrane Database of Systematic Reviews. Alpha blocker treatment for men to increase chances to have urinary catheter successfully removed The benefit was confirmed for alfuzosin, tamsulosin, and silodosin, though not for doxazosin.17Cochrane Database of Systematic Reviews. Alpha blockers for prevention of recurrent acute urinary retention and trial without catheter in men One trial specifically looking at tamsulosin found that about half of the men taking it avoided recatheterization on the day of the trial, compared to about a quarter on placebo.18PubMed. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia
In practice, the medication is typically started two to three days before the planned catheter removal to allow it to reach full effect. This is one of the clearest evidence-based interventions available for improving voiding trial outcomes.
Risk Factors for Failing a Voiding Trial
Not everyone passes on the first attempt, and certain factors make failure more likely. Some of these are modifiable, while others simply inform expectations.
Among surgical patients, the type of anesthesia is one of the strongest predictors. Spinal anesthesia with hyperbaric bupivacaine carried an eight-fold increase in the risk of needing catheterization in one observational study, while articaine (another spinal agent) tripled the risk. Longer surgeries, being over 60, and arriving at the recovery unit with a bladder already holding 250 mL or more all independently raised the risk as well.19PubMed Central. Postoperative urinary retention: risk factors, bladder filling rate and time to catheterization: an observational study as part of a randomized controlled trial Comorbidities, the specific type of surgery, and whether regional or general anesthesia was used all contribute.20PubMed Central. Postoperative urinary retention (POUR): A narrative review
For men with prostatic enlargement, the degree to which the prostate protrudes into the bladder is a reliable predictor. Graded on ultrasound from 1 (mild) to 3 (severe), patients with grade 3 intravesical prostatic protrusion had a roughly two-thirds failure rate, compared to about a third for grade 1.21PubMed. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention This grading can be done with a simple bedside ultrasound, and higher grades of protrusion had significantly worse outcomes across multiple studies.22PubMed Central. Predicting Outcome of Trial of Voiding Without Catheter in Acute Urinary Retention with Intravesical Prostatic Protrusion
What Happens When the Trial Fails
Failing a voiding trial doesn’t mean the bladder is permanently impaired. In most postoperative cases, the retention resolves within days as swelling decreases and anesthetic effects wear off. The question is how to manage urinary drainage in the meantime.
The two main options are putting an indwelling catheter back in or teaching the patient to perform clean intermittent self-catheterization (CIC) at regular intervals until voiding recovers. A randomized trial after prolapse surgery compared the two approaches and found that CIC was clearly preferable: the infection rate was less than half that of indwelling catheters (about 12% versus 33%), and the total duration of catheter dependence was dramatically shorter, averaging 18 hours for CIC versus 72 hours for a reinstalled indwelling catheter. Patient satisfaction was similar between the two groups.23PubMed. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial
Failing a voiding trial also raises the likelihood of developing a urinary tract infection in the near term. After a minimally invasive prostate procedure, patients who failed the trial were about four times more likely to develop a UTI than those who passed.24PubMed. Risk Factors and Real-World Short-Term Outcomes of a Failed Trial of Void After Rezum Therapy in a Multiethnic Population This makes the choice of post-failure drainage method even more relevant: anything that reduces catheter dwell time will tend to reduce infection risk.
Should You Get a Second Attempt
A natural question for anyone who fails the first trial is whether a second attempt is worth trying before committing to longer-term catheter management. The answer depends partly on the clinical setting and partly on cost.
A cost analysis looking at postoperative urogynecologic patients found that allowing a single voiding trial was less expensive (about $1,270 per patient) than offering two attempts (about $1,670 per patient). The main cost driver for two attempts was additional time in the recovery area. Two attempts only became cost-effective in scenarios where the recovery-room time cost was very low or when first-attempt pass rates were poor.7American Journal of Obstetrics and Gynecology. Two pee or not two pee: a cost analysis of second postoperative void trials In practice, many patients who fail a first backfill-assisted trial are sent home with a catheter or CIC instructions and a repeat trial is scheduled within a few days in the office.
Voiding Trials in Special Populations
The standard protocol described above works well for most postoperative and post-retention situations, but some populations require a different mindset entirely.
In spinal cord injury, the transition away from an indwelling catheter is a long-term process rather than a single test. At admission to specialized spinal cord injury units, about 91% of patients had indwelling catheters, while by discharge, intermittent catheterization was the most common method, used by about 46% of patients, followed by reflex voiding in roughly 29%. The bladder management strategy correlated strongly with the level and severity of the injury, and obesity independently influenced which approach was feasible.1Spinal Cord. Monitoring of neurogenic bladder management from hospital admission until discharge in spinal cord injury units: the SIRCA study
In children, voiding trials take on additional complexity because the bladder is still developing. Pediatric patients with artificial urinary sphincters, for example, may not void to completion spontaneously. One study found that about half of children with an artificial sphincter in place could void completely on their own, about a quarter needed to self-catheterize after voiding to empty the rest, and about a quarter relied entirely on catheterization. Children who had the device placed before puberty were significantly less likely to achieve independent voiding.25PubMed. Artificial urinary sphincter in children–voiding or emptying? An evaluation of functional results in 44 patients For these patients, the “voiding trial” isn’t a binary pass-fail event so much as an assessment of what combination of voiding and catheterization will be their long-term routine.
Common Misconceptions About Voiding Trials
One widespread misunderstanding is that failing a voiding trial means something is seriously wrong. In reality, transient urinary retention after surgery is common and usually resolves within a few days. Another misconception is that catheterization for a PVR check is necessary every time. Bladder scanners are accurate enough for routine use and spare the patient an uncomfortable procedure. Only when a scanner gives a suspicious reading, such as a PVR that doesn’t match the clinical picture, or when pelvic masses might be confusing the device, does catheterization need to be considered.
Patients also sometimes believe that drinking a lot of water will help them pass the trial faster. For an active trial where the bladder is pre-filled, this isn’t relevant. For a passive trial, modest hydration can help urine production, but overhydrating can lead to bladder overdistension if retention is present, which can actually make things worse. Following the nursing team’s fluid instructions is more useful than improvising your own hydration strategy.
Finally, there’s the assumption that the voiding trial is purely about bladder muscle strength. In many cases, the issue isn’t the bladder’s ability to contract but rather swelling, nerve effects from anesthesia, medication side effects (especially opioids), or mechanical obstruction. The cause of the retention shapes both the expected timeline for recovery and the right management approach if the trial doesn’t go well the first time.